Regarding to USP10, its overexpression is positively associated with a poor prognosis in glioblastoma,[23] esophageal squamous cell carcinoma,[21] pancreatic cancer,[24] et al., while its overexpression has negative clinical relevance in lung cancer,[22] indicating a cancer‐specific links in the prediction of cancer prognosis. This evidence concerns the gene USP10 and glioblastoma.